kff 2025 employer health benefits survey glp-1 coverage Benefit This chart, from the annual

It also protects and stimulates -cell proliferation, decreases liver glucose production via gluconeogenesis, enhances insulin secretion, decreases insulin resistance, decreases fasting blood glucose, and produces a significant rise in serum insulin [98,101,102]

It is provided for general informational and educational purposes and does not constitute medical advice, clinical guidance, or a substitute for the independent professional judgment of a licensed physician or other qualified healthcare provider

due to family history, radiation exposure

Cefalu et al

A separate study from Mass General Brigham found that women who discontinued GLP-1 medications before or early in pregnancy gained an average of 7.2 pounds more during pregnancy and experienced higher rates of gestational diabetes, hypertensive disorders, and preterm birth

Reasons for discontinuation of GLP1 receptor agonists: Data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes